Melo RS, Marques FR. Exclusion payment agreements between reference and generic drug companies: restrictive practices of competition? PIDCC [Internet]. 2015 Feb. 1 [cited 2026 Aug. 8];4(1):392-420. Available from: https://pidcc.com.br/pidcc/article/view/98